financetom
Business
financetom
/
Business
/
Macquarie to repay Australian investors $211 million after pension fund collapse
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Macquarie to repay Australian investors $211 million after pension fund collapse
Sep 24, 2025 5:36 PM

SYDNEY (Reuters) -Australia's Macquarie Group ( MCQEF ), will repay A$321 million ($211.35 million) to thousands of customers who invested their retirement savings into the now-collapsed Shield Master Fund, the country's corporate regulator said on Thursday.

The Australian Securities and Investments Commission (ASIC) has launched Federal Court proceedings against Macquarie Investment Management after it failed to act "efficiently, honestly and fairly" by not placing Shield under heightened monitoring.

The unit oversaw A$321 million ($211.35 million) in pension investments into Shield by nearly 3,000 people through Macquarie between 2022 and 2023, the regulator said.

"Many members thought their funds were safe when they used Macquarie's super platform to invest in Shield, which had no track record," ASIC deputy chair Sarah Court said in a statement.

The ASIC action is the second major run in between Macquarie and the corporate regulator since May.

ASIC began legal action against the bank alleging it misreported up to 1.5 billion short sales over the past 15 years - marking the fourth action against Macquarie in the past year.

The Shield fund was offered on a Macquarie platform which has hundreds of investment options which can be accessed through a financial advisor.

Macquarie, in a separate statement, said it would repay by Tuesday the full amount lost in Shield's collapse.

Macquarie will then attempt to recoup some of the funds lost by its investors through the Shield liquidation process that is being led by Alvarez & Marsal.

Macquarie said the process of recovering the funds could take many years.

The Shield Master Fund was put into liquidation in 2024 and is being investigated by ASIC for mishandling retirees money.

ASIC said it would not seek penalties given Macquarie's cooperation and the 'strong public interest' in securing timely court-based resolution.

It said Macquarie had agreed to enhance investment governance processes on its wrap platform under a plan agreed with the Australian Prudential Regulation Authority.

($1 = 1.5188 Australian dollars)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Once a beacon of stability, Vietnam to name third president in a year
Once a beacon of stability, Vietnam to name third president in a year
Mar 22, 2024
HANOI, March 22 (Reuters) - Communist-ruled Vietnam is seeking its third president in little more than a year after the resignation of Vo Van Thuong, who was only elected last year after the sudden dismissal of his predecessor. With accumulated foreign direct investment higher than its gross domestic product, Vietnam's stability is crucial to multinationals with large operations in the...
Cathie Wood's ARK Invest scoops up nearly 10,000 Reddit shares in debut
Cathie Wood's ARK Invest scoops up nearly 10,000 Reddit shares in debut
Mar 22, 2024
(Reuters) - Popular investor Cathie Wood's ARK Invest bought nearly 10,000 shares of Reddit ( RDDT ) in the social media platform's strong market debut on Thursday, an email from the asset manager showed. A total of 9,982 shares of the loss-making company was added to ARK Next Generation Internet ETF ( ARKW ) and ARK Fintech Innovation ETF (...
Hutchmed Begins Registration Stage for Phase 2/3 Trial of Investigational Autoimmune Disorder Drug
Hutchmed Begins Registration Stage for Phase 2/3 Trial of Investigational Autoimmune Disorder Drug
Mar 22, 2024
05:04 AM EDT, 03/22/2024 (MT Newswires) -- Hutchmed ( HCM ) said late Thursday it has started the registration stage for a phase 2/3 clinical trial of investigational drug sovleplenib for adult patients with warm antibody autoimmune hemolytic anemia in China. The move follows positive data from the proof-of-concept phase 2 stage of the trial and a consultation with the...
Japan's union group Rengo announces biggest wage hikes on record
Japan's union group Rengo announces biggest wage hikes on record
Mar 22, 2024
TOKYO (Reuters) -Japanese firms have agreed to raise pay by 5.25% this year, the biggest rise under comparable data since 2013, the country's largest union group Rengo confirmed on Friday. The results of the closely-watched wage negotiations are announced in several stages, in which the blue-chip firms are first to wrap up their talks in mid-March. The second announcement on...
Copyright 2023-2026 - www.financetom.com All Rights Reserved